TECHBio-Techne
$72.79+20% 1Y
$72.79
$43.2252 weeks$72.79
Latest close: a new 52-week highNov 6, 2026what changed →
Debt and balance sheet
Can TECH take a bad year?
Bio-Techne holds $150M more cash than debt.
$150M
Net cash · as at Sep 30, 2026 · cash and short-term investments less total debt
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 28.62
Altman Z-score · above the 2.6 line in Altman's model
- Interest cover
- 27.2×
Interest cover · operating profit divided by the interest bill
Details›
- Total debtSep 30, 2026
- $200M
- Cash and short-term investments
- $350M
- Net cash
- $150M
- EBITDA, trailing twelve months
- $320M
- Operating profit, trailing twelve months
- $241M
- Debt / equity
- 0.09×
- Total debt / EBITDA
- 0.63×
- Annualised volatilitytwo years of daily moves
- 44%
- Worst drawdown on file
- −67%
- Below its 52-week high
- 0.00%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Debt and solvency
What it owes against what it owns, and the Altman Z″ score built from it.
How far it has fallen
How much the price moves, how deep and how long its falls have run, and the return per unit of volatility.
On our screensStocks with more cash than debt
Biotechnology
The closest names by size in the same industry